Repurposing riluzole as an anti-osteosarcoma agent
Frontiers - 05 May 2025Repurposing riluzole as an anti-osteosarcoma agent ...
osteosarcoma
Repurposing riluzole as an anti-osteosarcoma agent ...
Metastatic Osteosarcoma Treatment Market Benefits from
openPR.com - 08 May 2025Metastatic Osteosarcoma Treatment Market Benefits from ...
KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1
Nature - 12 Apr 2025KPNA2 promotes osteosarcoma progression by regulating the alternative splicing of DDX3X mediated by YBX1 ...
Mystery of What Accelerates Osteosarcoma Development Uncovered
Inside Precision Medicine - 14 Jan 2025Mystery of What Accelerates Osteosarcoma Development Uncovered ...
Unmasking Nrf2 as a key driver of treatment resistance in osteosarcoma
News-Medical - 20 Apr 2025Unmasking Nrf2 as a key driver of treatment resistance in osteosarcoma ...
Osteosarcoma Treatment
St. Jude Children's Research Hospital - 27 Jun 2024Osteosarcoma Treatment ...
FDA Grants B7-H3–Targeted ADC Breakthrough Status in Osteosarcoma
Targeted Oncology - 08 Jan 2025FDA Grants B7-H3–Targeted ADC Breakthrough Status in Osteosarcoma ...
OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040
Yahoo Finance - 07 May 2025OS Therapies Announces Issuance of U.S. Patent #12,239,738 Protecting Commercial Manufacturing Market Exclusivity for OST-HER2 in Rare Pediatric Cancer Osteosarcoma and Full Listeria Cancer Immunotherapy Platform into 2040 ...
Dr Livingston on the Addition of Hydroxychloroquine to Gemcitabine/Docetaxel in Osteosarcoma
OncLive - 10 Feb 2025Dr Livingston on the Addition of Hydroxychloroquine to Gemcitabine/Docetaxel in Osteosarcoma ...
New Study Supports SBRT as Safe, Effective for Osteosarcoma
Cleveland Clinic - 30 Sep 2024New Study Supports SBRT as Safe, Effective for Osteosarcoma ...
An analysis of extraskeletal osteosarcoma based on the literature
Nature - 06 Jan 2025An analysis of extraskeletal osteosarcoma based on the literature ...
Exploring osteosarcoma based on the tumor microenvironment
Frontiers - 07 Nov 2024Exploring osteosarcoma based on the tumor microenvironment ...
Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells
Nature - 07 Apr 2025Static magnetic field promotes the doxorubicin toxicity effects on osteosarcoma cells ...
Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma - Oncogene
Nature - 11 Dec 2024Frequent copy number gain of MCL1 is a therapeutic target for osteosarcoma - Oncogene ...
Carbon minibeam radiation therapy results in tumor growth delay in an osteosarcoma murine model
Nature - 01 Mar 2025Carbon minibeam radiation therapy results in tumor growth delay in an osteosarcoma murine model ...
Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma
Nature - 24 Feb 2025Targeting AKT as a promising strategy for SOX2-positive, chemoresistant osteosarcoma ...
Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma
Nature - 27 Feb 2025Menin inhibitor MI-503 exhibits potent anti-cancer activity in osteosarcoma ...
Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis
Nature - 24 Mar 2025Identification and characterization of mitochondrial autophagy-related genes in osteosarcoma and predicting clinical prognosis ...
Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening
Nature - 17 Mar 2025Long non-coding RNA AC133552.2: biomarker and therapeutic target in osteosarcoma via PANoptosis gene screening ...